Optic nerve atrophy (ONA) is degeneration of, or damage to, the optic nerve, a cluster of nerves which carry visual information from the eye to the brain. ONA is mild to severe damage to the optic nerve that can adversely affect central vision, peripheral vision and color vision. ONA that occurs as a child may result in nystagmus (rhythmic involuntary eye movements). Causes of ONA include heredity, trauma (including stroke), a tumor, glaucoma, decrease in oxygen or blood supply, infections, or disorders. The effects of ONA have a broad range depending on the adequacy of visual messages sent from the eyes to the brain, from little or no visual impairment to near-total blindness. The condition may affect one or both eye. The optic nerve transports visual information from the eye to an area of the brain where it is processed.
Optic atrophy may be inherited or may result from brain injury or conditions such as brain trauma, inflammation, degenerative disorders, hemorrhage or a tumor. How Is Optic Nerve Atrophy Diagnosed? Paleness (pallor) of the typically pinkish optic nerve is observed by the eye M.D. during dilated examination with an ophthalmoscope. Testing usually includes an assessment of visual acuity, pupils and examiner observation of alignment, head position, and nystagmus. In older patients, peripheral vision and color vision assessment MRI scan, electroretinography (ERG), the visual evoked potential (VEP) and optical coherence tomography (OCT) may be performed to detect ONA. Once the stem cells are administered into the retrobulbar space they can begin honing in on damaged tissue signals. The Mesenchymal Stem Cells (MSCs) can differentiate into ganglion cells, optic nerve cells, retinal pigment epithelial cells, photoreceptor, and other eye-related cells. The differentiated cells can eventually treat lesions in optic nerves and retinal pigment cells. Most patients with optic nerve atrophy Global Stem Cells has helped to receive access to innovative treatments, using adult MSCs showed good improvement in visual acuity, visual field, light sensitivity, night vision, strabismus, and nystagmus.
Moreover, stem cell treatment for optic nerve had resulted in significantly slowed down further vision loss in patients with progressive conditions. Optic Nerve Atrophy is when optic nerve fibers deteriorate or become damaged and lead to partial or complete vision loss. Standard treatments to improve nerve tissue metabolism and stimulate its function include vitamins, enzymes, amino acids, and immunostimulants. Optic Nerve Atrophy (ONA) patients treated with stem cells Supplements usually observe improvements in the following areas: For patients who suffer from Optic Nerve Injuries or Optic Nerve Atrophy (ONA), this treatment can restore some of the fibers through missing optic nerve cells and eventually improve eyesight, field of vision and color discrimination capacity. We believe that there is always hope and that patients deserve access to effective and safe treatments.
We are independent of an in-house medical department. We combine internationally accredited hospitals, next-generation treatments, unique products and services that are integrative and effective to ensure the best possible treatment results. In terms of stem cells, we will make sure that the patient will receive the correct and necessary stem cell type, quality, quantity, and viability. Our exclusive research partner guarantee a stem cell viability of more than 90%, many injections have a staggering viability of 95-96%.
Optic nerve atrophy treatment in India at Stemcellcure relies on better functioning and better health of the optic nerve, with our treatment we stimulate the optic nerve which induces it to function better. Our treatment also helps improve the blood supply to the optic nerve which brings about the better health of the optic nerve. Our treatment helps in stopping the damage of the nerve cells between retinal ganglion cell axons and the lateral geniculate body (anterior visual system) thereby stopping any further degeneration of the optic nerve.